Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Amgen Raises FY2025 Sales Guidance from $35.000B-$36.000B to $35.800B-$36.600B vs $35.659B Est

Author: Benzinga Newsdesk | November 04, 2025 04:36pm

2025 Guidance

For the full year 2025, the Company expects:

Total revenues in the range of $35.8 billion to $36.6 billion.
On a GAAP basis, EPS in the range of $13.76 to $14.60, and a tax rate in the range of 14.5% to 16.0%.
On a non-GAAP basis, EPS in the range of $20.60 to $21.40, and a tax rate in the range of 15.0% to 16.5%.
Capital expenditures in the range of $2.2 billion to $2.3 billion.
Share repurchases not to exceed $500 million.

Posted In: AMGN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION